You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CPT2 antibody [1C2AE6 ] (ab110293)

MSCatalog No. MS722

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CPT2 antibody [1C2AE6 ]
See all CPT2 products (6) ...

Description

Mouse monoclonal [1C2AE6 ] to CPT2

Tested applications

IHC-P, ICC/IF, Flow Cyt, IP, In-Cell ELISAmore details

Cross reactivity

Reacts with

Mouse, Rat, Cow, Human

Immunogen

Human liver mitochondria

Positive control

HepG2 cells. HL-60 cells. Human normal colon FFPE tissue

Properties

Form

Liquid

Storage instructions

Store at +4°C. Do not freeze.

Storage buffer

Preservative: 0.02% Sodium azide
Constituent: HBS

Concentration

Concentration information loading...

Purity

Ammonium Sulphate Precipitation

Purification notes

Purity near homogeneity as judge by SDS-PAGE. The antibody was produced in-vitro using hybridomas grown in serum-free medium and then purified by biochemical fractionation.

Clonality

Monoclonal

Clone number

1C2AE6

Isotype

IgG1

Light chain type

kappa

  • Immunocytochemistry/ Immunofluorescence - CPT2 antibody [1C2AE6 ] (ab110293)Immunocytochemistry/ Immunofluorescence - CPT2 antibody [1C2AE6 ] (ab110293) image (enlarge)

  • Flow Cytometry - CPT2 antibody [1C2AE6 ] (ab110293)Flow Cytometry - CPT2 antibody [1C2AE6 ] (ab110293) image (enlarge)

  • Immunoprecipitation - Anti-CPT2 antibody [1C2AE6 ] (ab110293)Immunoprecipitation - Anti-CPT2 antibody [1C2AE6 ] (ab110293) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab110293 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Pathway

Lipid metabolism; fatty acid beta-oxidation.

Involvement in disease

Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency (CPT2D) [MIM:255110, 600649]; also known as CPT-II deficiency or CPT2 deficiency. CPT2D is an autosomal recessive disorder characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are triggered by prolonged exercise, fasting or viral infection and patients are usually young adults. In addition to this classical, late-onset, muscular type, a hepatic or hepatocardiomuscular form has been reported in infants. Clinical pictures in these children or neonates include hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy and sudden death.
Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency, lethal neonatal (CPT2D-LN) [MIM:608836]; also known as lethal neonatal CPT-II deficiency. It is a lethal neonatal form of CPT2D. This rarely presentation is antenatal with cerebral periventricular cysts and cystic dysplastic kidneys. The clinical variability of the disease is likely attributed to the variable residual enzymatic activity.

Sequence similarities

Belongs to the carnitine/choline acetyltransferase family.

Cellular localization

Mitochondrion inner membrane.

Target information above from: UniProt accessionP23786 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • mitochondrial antibody
  • ab110293 antibody
  • Carnitine O palmitoyltransferase 2 antibody
  • Carnitine O palmitoyltransferase 2 mitochondrial antibody
  • Carnitine O-palmitoyltransferase 2 antibody
  • Carnitine palmitoyltransferase II antibody
  • CPT 1 antibody
  • CPT 2 antibody
  • CPT II antibody
  • CPT1 antibody
  • CPT2 antibody
  • CPT2_HUMAN antibody
  • CPTASE antibody
  • CPTII antibody
  • MS722 antibody
see all

Anti-CPT2 antibody [1C2AE6 ] images:

  Immunocytochemistry/ Immunofluorescence - CPT2 antibody [1C2AE6 ] (ab110293)

Immunocytochemistry/ Immunofluorescence - CPT2 antibody [1C2AE6 ] (ab110293)

Immunocytochemistry image of ab110293 stained Human HepG2 cells. The cells were paraformaldehyde fixed (4%, 20 min) and Triton X-100 permeabilized (0.1%, 15 min). The cells were incubated with ab110293 at 4 µg/ml for 2h at room temperature, or over night at 4°C. The secondary antibody was (red) Alexa Fluor® 594 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. 10% Goat serum was used as the blocking agent for all blocking steps. DAPI was used to stain the cell nuclei (blue). Target protein locates mainly in mitochondria.

  Flow Cytometry - CPT2 antibody [1C2AE6 ] (ab110293)

Flow Cytometry - CPT2 antibody [1C2AE6 ] (ab110293)

HL-60 cells were stained with 1 µg/mL of ab110293 (blue) or an equal amount of an isotype control antibody (red) and analyzed by flow cytometry.

  Immunoprecipitation - Anti-CPT2 antibody [1C2AE6 ] (ab110293)

Immunoprecipitation - Anti-CPT2 antibody [1C2AE6 ] (ab110293)

As an IP antibody, MS722 works with human, bovine, rat, and mouse samples.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT2 antibody [1C2AE6 ] (ab110293)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPT2 antibody [1C2AE6 ] (ab110293)

IHC image of CPT2 staining in Human normal colon formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab110293, 10µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-CPT2 antibody [1C2AE6 ] (ab110293)

ab110293 has not yet been referenced specifically in any publications.

Publishing research using ab110293? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"